what dietary recommendations should be given to a patient with pre dialysis end stage kidney disease

ATI RN

ATI Capstone Adult Medical Surgical Assessment 2

1. What dietary recommendations should be given to a patient with pre-dialysis end-stage kidney disease?

A. Reduce phosphorus intake to 700 mg/day
B. Increase sodium intake
C. Increase protein intake
D. Increase potassium intake

Correct answer: A

Rationale: The correct recommendation for a patient with pre-dialysis end-stage kidney disease is to reduce phosphorus intake to 700 mg/day. High phosphorus levels can lead to complications in such patients. Increasing sodium intake (Choice B) is generally not recommended due to its association with hypertension and fluid retention. While protein is essential, increasing protein intake (Choice C) in kidney disease can be harmful as it can lead to increased waste products that the kidneys may struggle to excrete. Increasing potassium intake (Choice D) is not advisable as well, as patients with kidney disease may already have difficulty excreting potassium, leading to hyperkalemia.

2. What are the expected ECG changes in hypokalemia?

A. Flattened T waves
B. ST elevation
C. Wide QRS complex
D. Tall T waves

Correct answer: A

Rationale: Flattened T waves are the most common ECG change seen in patients with hypokalemia. Hypokalemia leads to a decrease in serum potassium levels, affecting the repolarization phase of the cardiac action potential. This results in T wave flattening or inversion. ST elevation is typically seen in conditions like myocardial infarction, not in hypokalemia. Wide QRS complex is more associated with hyperkalemia than hypokalemia. Tall T waves are often seen in hyperkalemia, not hypokalemia.

3. What is the first medication to administer for a patient experiencing wheezing due to an allergic reaction?

A. Albuterol 3 ml via nebulizer
B. Cromolyn 20 mg via nebulizer
C. Methylprednisolone 100 mg IV
D. Aminophylline 500 mg IV

Correct answer: A

Rationale: The correct answer is A, Albuterol 3 ml via nebulizer. Albuterol is the first-line medication for wheezing due to its rapid bronchodilatory effects. Choice B, Cromolyn, is used more for preventing allergic reactions rather than acute relief of wheezing. Choice C, Methylprednisolone, is a steroid used for its anti-inflammatory effects and is not the initial choice for acute relief of wheezing. Choice D, Aminophylline, is a bronchodilator but is not the first-line treatment for wheezing due to allergic reactions.

4. What is the first medication to give for wheezing due to an allergic reaction?

A. Albuterol via nebulizer
B. Cromolyn 20 mg via nebulizer
C. Methylprednisolone 100 mg IV
D. Aminophylline 500 mg IV

Correct answer: A

Rationale: Albuterol is the first-line medication for treating wheezing due to an allergic reaction. Albuterol is a short-acting beta-agonist that helps relieve bronchospasm quickly. Cromolyn is more commonly used for the prevention of asthma symptoms rather than for acute treatment. Methylprednisolone and aminophylline are not the first-line medications for acute wheezing due to an allergic reaction.

5. What are the early signs of increased intracranial pressure (IICP)?

A. Restlessness, irritability, and confusion
B. Sudden onset of seizures
C. Decreased heart rate and pupillary response
D. Loss of consciousness

Correct answer: A

Rationale: The correct answer is A: Restlessness, irritability, and confusion are early signs of increased intracranial pressure (IICP). These signs indicate that the brain is starting to experience pressure, often due to conditions such as trauma, tumors, or hemorrhage. Sudden onset of seizures (choice B) is not typically an early sign of IICP but can occur later as the pressure increases. Decreased heart rate and pupillary response (choice C) are more indicative of late-stage IICP as the brainstem becomes compromised. Loss of consciousness (choice D) is a late sign of IICP when the pressure has significantly increased and is causing significant brain dysfunction.